Formulation and evaluation of diltiazem hydrochloride gels for the treatment of anal fissures

Scientia Pharmaceutica

Volumn 77, Issue 2, 2009, Pages 465-482

  Dhawan, Sanju ^a   Medhi, Bikash ^b   Chopra, Sunny ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bioadhesion; Chronic anal fissure; Diltiazem hydrochloride; Gastrointestinal quality of life index; Rheology

Indexed keywords

DILTIAZEM; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; METHYLCELLULOSE;

ACCURACY; ADULT; AGED; ANUS FISSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; FEMALE; FLOW KINETICS; GASTROINTESTINAL QUALITY OF LIFE INDEX; GEL; HUMAN; HUMIDITY; IN VITRO STUDY; MALE; PARTICULATE MATTER; PH; SHEAR FLOW; SHEAR RATE; STAIN; THERMAL EXPOSURE; THIXOTROPY; VISCOSITY;

EID: 67149128715     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0903-10     Document Type: Article

References (22)

1. Kirsch J. Anal fissure. Wien Med Wochenschr. 2004; 154: 69-72. doi:10.1007/s10354-004-0038-43 (Pubitemid 38367085)
2. Antropoli C, Perrotti P, Rubino M, Martino A, De Stefano G, Migliore G, Antropoli M, Piazza P. Nifedipine for local use in conservative treatment of anal fissures: preliminary results of a multicenter study. Dis Colon Rectum. 1999; 42: 1011-1015. doi:10.1007/BF02236693 (Pubitemid 29383829)
3. Corman M. Anal Fissure. In: Corman M, editor. Colon and rectal surgery. Philadelphia, PA: Lippincott-Raven; 1998. p. 206-223.
4. Dziki A, Trzcinski R, Langner E, Wronski W. New approaches to the treatment of anal fissure. Acta Chir Iugosl. 2002; 49: 73-75. doi:10.2298/ACI0202073D
5. Acheson AG, Scholefield JH. Pharmacological advancements in the treatment of chronic anal fissure. Expert Opin Pharmacother. 2005; 6: 2475-2481. doi:10.1517/14656566.6.14.2475 (Pubitemid 41701049)
6. Lubowski DZ. Anal fissures. Aust Fam Physician. 2000; 29: 839-844. PMid:1108386
7. Allan A, May R. Anal fissure. Br J Hosp Med. 1985; 33: 41-43. PMid:3971079
8. Dhawan S, Chopra S. Nonsurgical approaches for the treatment of anal fissures. Am J Gastroenterol. 2007; 102: 1312-1321. doi:10.1111/j.1572-0241. 2007.01203.x (Pubitemid 46802030)
9. Hager T. [Anal fissure.] Ther Umsch. 1997; 54: 190-192. PMid:9221541
10. Haq Z, Rahman M, Chowdhury RA, Baten MA, Khatun M. Chemical sphincterotomy - first line of treatment for chronic anal fissure. Mymensingh Med J. 2005; 14: 88-90. PMid:15695964
11. Gupta PJ. Current treatment options for fissure-in-ano. J Med Liban. 2004; 52: 33-38. PMid:15881700 (Pubitemid 40321778)
12. Nyam DC, Pemberton JH. Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum. 1999; 42: 1306-1310. doi:10.1007/BF02234220 (Pubitemid 29489364)
13. Garcia-Aguilar J, Belmonte C, Wong WD, Lowry AC, Madoff RD. Open vs. closed sphincterotomy for chronic anal fissure: long-term results. Dis Colon Rectum. 1996; 39: 440-443. doi:10.1007/BF02054061 (Pubitemid 26116876)
14. McCallion K, Gardiner KR. Progress in the understanding and treatment of chronic anal fissure. Postgrad Med J. 2001; 77: 753-758. doi:10.1136/pmj.77.914. 753 (Pubitemid 33116509)
15. Garrido R, Lagos N, Lattes K, Abedrapo M, Bocic G, Cuneo A, Chiong H, Jensen C, Azolas R, Henriquez A, Garcia C. Gonyautoxin: new treatment for healing acute and chronic anal fissures. Dis Colon Rectum. 2005; 48: 335-343 doi:10.1007/s10350-004-0893-894 (Pubitemid 40576566)
16. Attia MA, El-Gibaly I, Shaltout SE, Fetih GN. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int J Pharm. 2004; 276: 11-28. doi:10.1016/j.ijpharm.2004.01.041 (Pubitemid 38542984)
17. Kelner A, Schacht EH. Tailor-made polymers for local drug delivery: release of macromolecular model drugs from biodegradable hydrogels based on poly(ethylene oxide). J Control Rel. 2005; 101: 13-20. doi:10.1016/j.jconrel. 2004.09.010 (Pubitemid 39600968)
18. Jones DS, Woolfson AD, Brown AF, Coulter WA, McClelland C, Irwin CR. Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Rel. 2000; 67: 357-368. doi:10.1016/S0168- 3659(00)00231-235 (Pubitemid 30303848)
19. Franz TJ. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol. 1975; 64: 190-195. PMid:123263
20. USP-XXII. Rockwille, MD: United States Pharmacopoeial Convention Inc., Twinbrook Parkway.
21. Buckley MM, Grant SM, Goa KL, McTavish D, Sorkin EM. Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Drugs. 1990; 39: 757-806. PMid:2191851 (Pubitemid 20176249)
22. Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res. 1996; 13: 1734-1738. doi:10.1023/A:1016413428473 (Pubitemid 26426902)